Related Experiment Video
Updated: Jun 22, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative
Krystyna Pawlak1, Janina Tankiewicz, Michal Mysliwiec
1Department of Monitored Pharmacotherapy, 15-089 Bialystok, Poland.
Abstract:
The abnormalities of tissue factor (TF) and its inhibitor (TFPI) system could potentially contribute to high incidence of thrombotic complications and atherosclerosis in patients with chronic kidney disease (CKD). Recently, the role of the kynurenine (KYN) pathway of tryptophan (TRP) degradation has been postulated in the progression of cardiovascular complications. We compared the plasma TF, TFPI and the metabolites of TRP degradation: KYN and 3-hydroxykynurenine (3-HKYN) levels in 55 CKD patients on conservative treatment and 19 healthy controls; and we tried to establish whether or not there is an association between TF/TFPI system and above-mentioned metabolites in these patients. Compared with the controls, the patients with CKD showed a significant increase in plasma concentrations of TF (P < 0.01), KYN, 3-HKYN (both P < 0.0001), KYN-to-TRP (kyn/trp) ratio (P < 0.001) and 3-HKYN-to-KYN (3-hkyn/kyn) ratio (P < 0.05). In contrast, TRP concentrations were significantly decreased in the CKD group compared with controls (P < 0.001). The difference in TFPI levels between CKD patients and controls was not statistically significant. TF/TFPI system was inversely correlated with TRP, whereas it was positively related to the 3-HKYN, kyn/trp and 3-hkyn/kyn ratios. Moreover, both the TF/TFPI system and KYNs were associated with the markers of kidney function. These data suggested for the first time a significant relationship between TF/TFPI system and KYN pathway in CKD patients on conservative treatment.
Insights
Chronic kidney disease (CKD) patients show increased tissue factor (TF) and kynurenine (KYN) pathway metabolites. These findings suggest a link between the TF/TFPI system and KYN pathway in CKD, impacting thrombotic complications.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Abnormalities in the tissue factor (TF) and tissue factor pathway inhibitor (TFPI) system are linked to thrombotic complications and atherosclerosis in chronic kidney disease (CKD).
- The kynurenine (KYN) pathway of tryptophan (TRP) degradation has been implicated in the progression of cardiovascular complications.
Purpose of the Study:
- To compare plasma levels of TF, TFPI, and KYN pathway metabolites (KYN, 3-hydroxykynurenine [3-HKYN]) in CKD patients and healthy controls.
- To investigate the association between the TF/TFPI system and KYN pathway metabolites in CKD patients.
Main Methods:
- Plasma samples were collected from 55 CKD patients on conservative treatment and 19 healthy controls.
- Concentrations of TF, TFPI, TRP, KYN, and 3-HKYN were measured.
- Statistical analyses were performed to compare groups and assess correlations.
Main Results:
- CKD patients exhibited significantly higher plasma TF, KYN, 3-HKYN, KYN/TRP ratio, and 3-HKYN/KYN ratio compared to controls.
- TRP concentrations were significantly lower in CKD patients.
- TF/TFPI system showed inverse correlation with TRP and positive correlation with 3-HKYN, KYN/TRP, and 3-HKYN/KYN ratios.
Conclusions:
- This study reveals a significant relationship between the TF/TFPI system and the KYN pathway in CKD patients.
- These findings suggest a potential role for the KYN pathway in the thrombotic complications associated with CKD.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management